Table 2.
Myocardial injury biomarkers.
| Variables | Patients | Comparisons (N) |
PHC (n) |
Control (n) |
Heterogeneity | Analysis model | MD | 95%CI | Overall effect P | |
|---|---|---|---|---|---|---|---|---|---|---|
| I2 | P | |||||||||
| cTnI | Adults | |||||||||
| Baseline | 10 | 230 | 135 | 0% | 0.88 | Fixed | −0.00 | −0.01 to 0.01 | 0.91 | |
| POD-1 | 10 | 230 | 135 | 85% | < 0.0001 | Random | −1.70 | −2.63 to −0.77 | 0.0003 | |
| CK | Adults | |||||||||
| Baseline | 3 | 90 | 30 | 0% | 0.40 | Fixed | 1.01 | −11.56 to 13.58 | 0.88 | |
| POD-1 | 3 | 90 | 30 | 0% | 0.67 | Fixed | −106.38 | −211.33 to −1.42 | 0.05 | |
| CK-MB | Adults | |||||||||
| Baseline | 5 | 120 | 45 | 0% | 0.98 | Fixed | 0.14 | −0.13 to 0.42 | 0.29 | |
| POD-1 | 6 | 150 | 75 | 79% | 0.0002 | Random | −11.32 | −20.34 to −2.30 | 0.01 | |
| MYO | Adults | |||||||||
| Baseline | 3 | 90 | 30 | 0% | 0.43 | Fixed | 0.03 | −2.86 to 2.92 | 0.98 | |
| POD-1 | 3 | 90 | 30 | 38% | 0.20 | Fixed | −38.51 | −92.34 to 15.33 | 0.16 | |
| cTnT | Pediatrics | |||||||||
| Baseline | 2 | 100 | 100 | 0% | 1.00 | Fixed | −0.00 | −0.00 to 0.00 | 0.16 | |
| POD-1 | 2 | 100 | 100 | 0% | 0.95 | Fixed | −0.10 | −0.12 to −0.09 | < 0.00001 | |
| CK | Pediatrics | |||||||||
| Baseline | 1 | 10 | 10 | NA | NA | Random | −149.00 | −276.53 to −21.47 | 0.02 | |
| POD-1 | 1 | 10 | 10 | NA | NA | Random | −621.00 | −1151.11 to −90.89 | 0.02 | |
| CK-MB | Pediatrics | |||||||||
| Baseline | 1 | 10 | 10 | NA | NA | Random | −5.00 | −16.64 to 6.64 | 0.40 | |
| POD-1 | 1 | 10 | 10 | NA | NA | Random | −43.00 | −59.00 to −27.00 | < 0.0001 | |
| AST | Pediatrics | |||||||||
| Baseline | 1 | 10 | 10 | NA | NA | Random | −3.00 | −15.40 to 9.40 | 0.64 | |
| POD-1 | 1 | 10 | 10 | NA | NA | Random | −40.00 | −66.48 to −13.52 | 0.003 | |
PHC Penehyclidine hydrochloride, MD Mean difference, CI Confidence interval, cTn Cardiac troponin, CK Creatine kinase, MYO Myoglobin, AST Aspartate transaminase, POD-1 Postoperative day-1, NA Not applicable